Latest Articles

An automated and cost-effective workflow in immunopeptidomics, utilizing microfluidics technology, has been created that overcomes limitations in sample preparation and could be a powerful tool for tumor antigen discovery in sparse samples.

This article explores the ability of chemicals used in plastic production to disrupt the normal function of hormones, namely in reproduction.

Researchers have developed a SERS chip that rapidly and accurately detects sulfur dioxide and nitrogen dioxide, gases emitted by vehicles and industries that contribute to acid rain and have also been linked to respiratory problems.

Scientists have identified a number of biomarkers associated with progression of Type 2 diabetes to predict insulin resistance development, which could help to manage the disease and improve patient outcomes.

What does a self-driving clinical trial look like and what does it mean for the industry? Explore the ins and outs of AI in clinical development in this article.

Our knowledge of how pathological proteins like amyloid spread and become deposited throughout the brain in many major neurodegenerative diseases is now extensive. Nevertheless, our improved understanding of Alzheimer’s molecular mechanisms has yet to bridge over to effective treatments that reverse disease progress. Are we any closer to a cure?

The next 10 years will likely bring gene editing to market for an array of rare conditions. However, making the potential benefits broadly available won’t be without roadblocks. Here, we explore some of the issues the industry will have to contend with.

Pressurized metered dose inhalers are the dominant form of treatment for millions of asthma sufferers. But, with the need to phase out high global warming potential propellants that are currently integral to device function, what does the future look like for pMDI use?

Last week, conclusions from an upcoming report by the International Agency for Research on Cancer (IARC) were leaked. Reuters reported that the IARC was set to list the sweetener aspartame as a “possible carcinogen”. What does aspartame’s new designation mean, and should it alter your food choices?

This article will discuss how cell models are enabling researchers to elucidate the underlying biological mechanisms of disease to support diagnostic and therapeutic development.